Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_1
1
20%
Ph phase_2
1
20%
Ph phase_4
1
20%
Ph phase_3
1
20%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(1)
Other(1)

Detailed Status

Recruiting2
Completed1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

recruiting240%
completed120%
not_yet_recruiting120%
unknown120%

Recent Activity

2 active trials
Showing 5 of 5
recruitingphase_3

A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive

NCT06930794
recruitingphase_1

A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers

NCT04626635
completednot_applicable

Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLC

NCT07053215
not_yet_recruitingphase_2

A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer

NCT06211023
unknownphase_4

Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC

NCT05098990

Clinical Trials (5)

Showing 5 of 5 trials
NCT06930794Phase 3

A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive

Recruiting
NCT04626635Phase 1

A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers

Recruiting
NCT07053215Not Applicable

Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLC

Completed
NCT06211023Phase 2

A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer

Not Yet Recruiting
NCT05098990Phase 4

Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5